Citations

Clear

9383 citation(s) found for "Thomas, PS".

Detection of Smallpox Virus DNA by LightCycler PCR
Espy, Mark J., Cockerill, Franklin R., Meyer, Richard F. , Bowen, Michael D. , Hadfield, Ted L., Smith, Thomas F., Poland, Gregory A.

Mayo Clinic

Journal of Clinical Microbiology | December 8, 2011 | Volume: 40 | Issue: 11 | Pages: 4405-4405

10.1128/jcm.40.11.4405.2002-a Get It

Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: [RETIRED]
Scott, Thomas F. , Frohman, Elliott, Sèze, de , Gronseth, Gary , Weinshenker, Brian G. , Seze, Jerome De , Weinshenker, Brian G

Mayo Clinic

Neurology | December 8, 2011 | Volume: 77 | Issue: 24 | Pages: 2128-2134

10.1212/wnl.0b013e31823dc535 | PMID 22156988 Get It

Next generation analytic tools for large scale genetic epidemiology studies of complex diseases
Mechanic, Leah E. , Chen, Huann‐Sheng , Chatterjee, Nilanjan , Cox, Nancy J. , Divi, Rao L., Fan, Ruzong , Harris, Emily , McAllister, Kimberly A. , Moore, Jason H. , Paltoo, Dina N., Province, Michael A. , Ramos, Erin M. , Ritchie, Marylyn D. , Roeder, Kathryn , Schaid, Daniel J. , Thomas, Duncan C. , Weinberg, Clarice R. , Witte, John S. , Zhang, Shunpu, Zöllner, Sebastian , Feuer, Eric J. , Gillanders, Elizabeth M. , Amos, Christopher I. , Jacobs, Kevin B. , Kraft, Peter , Leal, Suzanne M. , Stephens, Matthew , Weinberg, Clarice R , Province, Mike

Mayo Clinic

Genetic Epidemiology | December 6, 2011 | Volume: 36 | Issue: 1 | Pages: 22-35

10.1002/gepi.20652 | PMID 22147673 Get It

AbstractOver the past several years, genome‐wide association studies (GWAS) have succeeded in identifying hundreds of genetic markers associated with common diseases. However, most of these markers confer relatively small increments of risk and explain only a small proportion of familial clustering. To identify obstacles to future progress in genetic epidemiology research and provide recommendations to NIH for overcoming these barriers, the National Cancer Institute sponsored a workshop entitled “Next Generation Analytic Tools for Large‐Scale Genetic Epidemiology Studies of Complex Diseases” on September 15–16, 2010. The goal of the workshop was to facilitate discussions on (1) statistical strategies and methods to efficiently identify genetic and environmental factors contributing to the risk of complex disease; and (2) how to develop, apply, and evaluate these strategies for the design, analysis, and interpretation of large‐scale complex disease association studies in order to guide NIH in setting the future agenda in this area of research. The workshop was organized as a series of short presentations covering scientific (gene‐gene and gene‐environment interaction, complex phenotypes, and rare variants and next generation sequencing) and methodological (simulation modeling and computational resources and data management) topic areas. Specific needs to advance the field were identified during each session and are summarized.Genet. Epidemiol. 36 : 22–35, 2012. © 2011 Wiley Periodicals, Inc.
Difficult Cases of Pain and Nonpain Symptoms in Intractable Spinal Infections
Olsen, Molly L., Havyer, Rachel D. , Smith, Thomas J. , Swetz, Keith M. , Smith, Thomas J

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | December 5, 2011 | Volume: 29 | Issue: 6 | Pages: 493-496

10.1177/1049909111429121 | PMID 22144661 Get It

In the modern age of advanced surgical techniques and pharmacologic management, bacterial spinal infections (SIs) can be managed (either eradicated or suppressed) in many hosts. However, the optimal management of SIs may be limited by patient comorbidities, which do not allow for surgical management, or limited by antimicrobial options due to side effects, toxicities, or emerging drug resistance. In these settings, frank and honest discussion regarding risks and benefits of treatment should be pursued, including that the SI may be a terminal illness. In this case series, we present 3 patients who had bacterial SIs whose treatments were limited by the above-mentioned factors. Furthermore, each case presented challenges regarding optimal medical management of somatic and neuropathic pain associated with the SI.
Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients
Smith, Angela B. , Raynor, Mathew, Amling, Christopher L. , Busby, J. Erik, Castle, Erik P., Davis, Rodney , Nielsen, Matthew E. , Thomas, Raju , Wallen, Eric, Woods, Michael, Pruthi, Raj S.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | December 5, 2011 | Volume: 22 | Issue: 1 | Pages: 17-21

10.1089/lap.2011.0326 | PMID 22142028 Get It

Response to Letter Regarding Article, “Impact of Cardiac Rehabilitation on Mortality and Cardiovascular Events After Percutaneous Coronary Intervention in the Community”
Tilbury, R. Thomas, Squires, Ray W. , Thomas, Randal J. , Lennon, Ryan J. , Goel, Kashish , Thomas, Randal

Mayo Clinic

Circulation | November 28, 2011 | Volume: 124 | Issue: 22 | Pages: No page available

10.1161/circulationaha.111.061713 Get It

Patient-Centric Clinical Pharmacology Advances the Path to Personalized Medicine
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Mayo Clinic

Biomarkers in Medicine | November 21, 2011 | Volume: 5 | Issue: 6 | Pages: 697-700

10.2217/bmm.11.78 | PMID 22103605 Get It

Distribution and Associations of [−2]Proenzyme-Prostate Specific Antigen in Community Dwelling Black and White Men
Rhodes, Thomas , Jacobson, Debra J., McGree, Michaela E. , Sauver, Jennifer L. St. , Sarma, Aruna V. , Lieber, Michael M., Klee, George G., Demissie, Kitaw , Jacobsen, Steven J. , Girman, Cynthia J. , St Sauver, Jennifer L

Mayo Clinic

Journal of Urology | November 17, 2011 | Volume: 187 | Issue: 1 | Pages: 92-96

10.1016/j.juro.2011.09.060 | PMID 22093189 Get It

Benign Prostate Specific Antigen Distribution and Associations With Urological Outcomes in Community Dwelling Black and White Men
Rhodes, Thomas , Jacobson, Debra J., McGree, Michaela E. , Sauver, Jennifer L. St. , Sarma, Aruna V. , Lieber, Michael M., Klee, George G., Demissie, Kitaw , Jacobsen, Steven J. , Girman, Cynthia J. , St Sauver, Jennifer L

Mayo Clinic

Journal of Urology | November 17, 2011 | Volume: 187 | Issue: 1 | Pages: 87-91

10.1016/j.juro.2011.09.061 | PMID 22093190 Get It

A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32
Li, Dalin , Best, Timothy, Berg, David J. Van Den, Gourraud, Pierre‐Antoine , Cortessis, Victoria K. , Skol, Andrew D. , Mack, Thomas M. , Glaser, Sally L. , Weiss, Lawrence M. , Nathwani, Bharat N., Schumacher, Fredrick R. , Edlund, Christopher K., Hwang, Amie E. , Fredericksen, Zachary S., Strong, Louise C. , Link, Brian K. , Cerhan, James R. , Conti, David V. , Onel, Kenan , Cozen, Wendy , Bhatia, Ravi , Slager, Susan L. , Habermann, Thomas M. , Robison, Leslie L. , Cerhan, James R , Link, Brian K , Conti, David V

Mayo Clinic

Blood | November 16, 2011 | Volume: 119 | Issue: 2 | Pages: 469-475

10.1182/blood-2011-03-343921 | PMID 22086417 Get It

Nodular sclerosing Hodgkin lymphoma (NSHL) is a distinct, highly heritable Hodgkin lymphoma subtype. We undertook a genome-wide meta-analysis of 393 European-origin adolescent/young adult NSHL patients and 3315 controls using the Illumina Human610-Quad Beadchip and Affymetrix Genome-Wide Human SNP Array 6.0. We identified 3 single nucleotide polymorphisms (SNPs) on chromosome 6p21.32 that were significantly associated with NSHL risk: rs9268542 (P = 5.35 × 10−10), rs204999 (P = 1.44 × 10−9), and rs2858870 (P = 1.69 × 10−8). We also confirmed a previously reported association in the same region, rs6903608 (P = 3.52 × 10−10). rs204999 and rs2858870 were weakly correlated (r2 = 0.257), and the remaining pairs of SNPs were not correlated (r2 < 0.1). In an independent set of 113 NSHL cases and 214 controls, 2 SNPs were significantly associated with NSHL and a third showed a comparable odds ratio (OR). These SNPs are found on 2 haplotypes associated with NSHL risk (rs204999-rs9268528-rs9268542-rs6903608-rs2858870; AGGCT, OR = 1.7, P = 1.71 × 10−6; GAATC, OR = 0.4, P = 1.16 × 10−4). All individuals with the GAATC haplotype also carried the HLA class II DRB1*0701 allele. In a separate analysis, the DRB1*0701 allele was associated with a decreased risk of NSHL (OR = 0.5, 95% confidence interval = 0.4, 0.7). These data support the importance of the HLA class II region in NSHL etiology.